Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource rightarrow Blocking Peptide rightarrow ABL1  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
separator
ELISA Kit ELISA Kit
CLIA Kit CLIA Kit
PCR Kit PCR Kit
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
siRNA siRNA
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
separator
Our Best Sellers moreseparator
separator
 • D-3-phosphoglycerate dehydrogenase (PHGDH) Antibody
 • Plasmin ELISA Kit
 • Carbonic anhydrase ELISA Kit
 • Helicobacter pylori, Cag Antigen Antibody
 • Interferon beta (IFN-beta) ELISA Kit
 • Plexin A1 (Sema Domain) (PLXNA1) Antibody
 • Alpha-1-Antichymotrypsin (alpha1ACT) ELISA Kit
 • Visfatin (VF) ELISA Kit
 • 60S ribosomal protein L19 (Rpl19) Recombinant Protein
 • Taste receptor type 2 member 40 (TAS2R40) Recombinant Protein
 • CDw17 Antibody
 • Interleukin-13 protein (Il13) Recombinant Protein
 • Nerve Growth Factor (NGF) ELISA Kit
 • IGF1R Antibody
 downarrow more ...
separator
separator
DatasheetFull DatasheetPrinter Friendly DatasheetPrint This DatasheetAdd to Compare ListHave Questions? Ask UsRequest for a Quotation today

ABL1 blocking peptide :: ABL1/2 Blocking Peptide

Scan QR to view Datasheet Catalog #    MBS824165 ABL1 blocking peptide
Unit / Price
1 mg  /  $160 +1 FREE 8GB USB
5 mg  /  $305 +1 FREE 8GB USB
 
 Go to:   rightarrow  Product Names   rightarrow Product Info   rightarrow Accession #s   rightarrow Product Desc   rightarrow Diseases/Tissues/Pathways   rightarrow Applications   rightarrow References 
 Product Name   

ABL1/2, Blocking Peptide

 Also Known As   

ABL1/2 Blocking Peptide

 Product Synonym Names    ABL1; ABL; JTK7; Tyrosine-protein kinase ABL1; Abelson murine leukemia viral oncogene homolog 1; Abelson tyrosine-protein kinase 1; Proto-oncogene c-Abl; p150; ABL2; ABLL; ARG; Abelson tyrosine-protein kinase 2; Abelson murine leukemia viral oncogene homolog 2; Abelson-related gene protein; Tyrosine-protein kinase ARG
 Product Gene Name   

ABL1 blocking peptide

[Similar Products]
 Product Synonym Gene Name    ABL2 [Similar Products]
 Antibody/Peptide Pairs    ABL1/2 peptide (MBS824165) is used for blocking the activity of ABL1/2 antibody (MBS820417)
 Research Use Only    For Research Use Only. Not for use in diagnostic procedures.
Table BarTOPTable Bar
 OMIM    gene 608232
 3D Structure    ModBase 3D Structure for P00519
Section Bar
 Host    Synthetic
 Species Reactivity    Human, Mouse, Rat
Section Bar
 Purity/Purification    >85%
 Form/Format    Lyophilized powder
Section Bar
 Quality Control    The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.
Section Bar
 Preparation and Storage    Shipped at 4 degree C. Store at -20 degree C for one year.
 Other Notes    Small volumes of ABL1 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Table BarTOPTable Bar
 

Related Product Information for ABL1 blocking peptide

   The peptide is used to block Anti-ABL1/2 Antibody reactivity.
 Applications Tested/Suitable for ABL1 blocking peptide   

Blocking (BL)

 Application Notes for ABL1 blocking peptide    Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 degree C for overnight or at room temperature for 2 hours.
Table BarTOPTable Bar
NCBI/Uniprot data below describe general gene information for ABL1. It may not necessarily be applicable to this product.
 NCBI GI #    62362414
 NCBI GeneID    25
 NCBI Accession #    NP_005148.2 [Other Products]
 NCBI GenBank Nucleotide #    NM_005157.5 [Other Products]
Section Bar
 UniProt Primary Accession #    P00519 [Other Products]
 UniProt Secondary Accession #    Q13869; Q13870; Q16133; Q17R61; Q45F09; A3KFJ3 [Other Products]
 UniProt Related Accession #    P00519 [Other Products]
 Molecular Weight    124,955 Da
Table BarTOPTable Bar
 NCBI Official Full Name    tyrosine-protein kinase ABL1 isoform a
 NCBI Official Synonym Full Names    ABL proto-oncogene 1, non-receptor tyrosine kinase
 NCBI Official Symbol    ABL1 [Similar Products]
 NCBI Official Synonym Symbols   
ABL; JTK7; p150; c-ABL; v-abl; c-ABL1; bcr/abl
[Similar Products]
 NCBI Protein Information    tyrosine-protein kinase ABL1; proto-oncogene c-Abl; bcr/c-abl oncogene protein; Abelson tyrosine-protein kinase 1; c-abl oncogene 1, receptor tyrosine kinase; proto-oncogene tyrosine-protein kinase ABL1; v-abl Abelson murine leukemia viral oncogene homolog 1
 UniProt Protein Name    Tyrosine-protein kinase ABL1
 UniProt Synonym Protein Names   
Abelson murine leukemia viral oncogene homolog 1; Abelson tyrosine-protein kinase 1; Proto-oncogene c-Abl; p150
 Protein Family    Tyrosine-protein kinase
 UniProt Gene Name    ABL1 [Similar Products]
 UniProt Synonym Gene Names    ABL; JTK7 [Similar Products]
 UniProt Entry Name    ABL1_HUMAN
Section Bar
 NCBI Summary for ABL1    This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
Section Bar
 UniProt Comments for ABL1    Abl: an ubiquitously expressed and highly conserved proto-oncogenic tyrosine kinase. c-Abl protein is distributed in both the nucleus and the cytoplasm of cells. Negatively regulated by its SH3 domain, and deletion of the SH3 domain turns ABL1 into an oncogene. It has been implicated in regulation of cell proliferation, differentiation, apoptosis, cell adhesion and stress response. The Philadephia chromosome translocation t(9;22)(q34;q11) creates a Bcr-Abl fusion protein, responsible for 90% of chronic myelogenous leukemia (CML) and ~25% of acute lymphoblastic leukemia (ALL). Inhibitors: Gleevec (imatinib, Glivec), Dasatinib. Two alternatively-spliced isoforms have been described.

Protein type: Protein kinase, TK; Kinase, protein; Oncoprotein; EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family

Chromosomal Location of Human Ortholog: 9q34.1

Cellular Component: nucleoplasm; extrinsic to internal side of plasma membrane; nuclear membrane; mitochondrion; perinuclear region of cytoplasm; leading edge; cytoplasm; nucleolus; nucleus; cytosol; actin cytoskeleton

Molecular Function: actin monomer binding; protein C-terminus binding; non-membrane spanning protein tyrosine kinase activity; magnesium ion binding; protein kinase activity; actin filament binding; protein binding; syntaxin binding; DNA binding; protein-tyrosine kinase activity; manganese ion binding; mitogen-activated protein kinase binding; nicotinate-nucleotide adenylyltransferase activity; SH3 domain binding; ATP binding; receptor binding

Biological Process: DNA damage induced protein phosphorylation; positive regulation of apoptosis; cerebellum morphogenesis; negative regulation of BMP signaling pathway; transitional one stage B cell differentiation; B cell receptor signaling pathway; elevation of cytosolic calcium ion concentration; regulation of endocytosis; negative regulation of mitotic cell cycle; neuromuscular process controlling balance; cell cycle arrest; positive regulation of oxidoreductase activity; spleen development; mitosis; positive regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of peptidyl-tyrosine phosphorylation; muscle cell differentiation; DNA damage response, signal transduction resulting in induction of apoptosis; positive regulation of osteoblast proliferation; negative regulation of ubiquitin-protein ligase activity; autophagy; response to oxidative stress; actin cytoskeleton organization and biogenesis; axon guidance; peptidyl-tyrosine phosphorylation; alpha-beta T cell differentiation; platelet-derived growth factor receptor signaling pathway; mitochondrial depolarization; positive regulation of mitotic cell cycle; Bergmann glial cell differentiation; regulation of transcription, DNA-dependent; collateral sprouting; cell differentiation; B cell proliferation during immune response; epidermal growth factor receptor signaling pathway; regulation of cell adhesion; cell migration; mismatch repair; thymus development; activated T cell proliferation; DNA damage response, signal transduction; B-1 B cell homeostasis; protein modification process; regulation of cell proliferation; microspike biogenesis; innate immune response; positive regulation of muscle cell differentiation; regulation of autophagy; negative regulation of cell-cell adhesion; positive regulation of release of sequestered calcium ion into cytosol; blood coagulation; response to DNA damage stimulus

Disease: Leukemia, Chronic Myeloid
Table BarTOPTable Bar
 Research Articles on ABL1    1. BCR-ABL1 compound mutants confer different levels of tyrosine kinase inhibitor resistance, necessitating rational treatment selection to optimize clinical outcome.
Table BarTOPTable Bar
 Precautions    All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
 Disclaimer    While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Table BarTOPTable Bar
Products associated with ABL1 blocking peptidePathways associated with ABL1 blocking peptide
 Reference Product  PubMed Publications
 BCR blocking peptide  >807 publications with ABL1 and BCR
 SRC blocking peptide  >45 publications with ABL1 and SRC
 CRKL blocking peptide  >10 publications with ABL1 and CRKL
 GRB2 blocking peptide  >8 publications with ABL1 and GRB2
 CBL blocking peptide  >8 publications with ABL1 and CBL
 CRK blocking peptide  >7 publications with ABL1 and CRK
 ABI1 blocking peptide  >7 publications with ABL1 and ABI1
 RB1 blocking peptide  >5 publications with ABL1 and RB1
 DOK1 blocking peptide  >2 publications with ABL1 and DOK1
 ATM blocking peptide  >2 publications with ABL1 and ATM
 Products by Pathway  Pathway Diagram
 Alpha6-Beta4 Integrin Signaling Pathway antibodies  Alpha6-Beta4 Integrin Signaling Pathway Diagram
 Axon Guidance Pathway antibodies  Axon Guidance Pathway Diagram
 Axon Guidance Pathway antibodies  Axon Guidance Pathway Diagram
 Axon Guidance Pathway antibodies  Axon Guidance Pathway Diagram
 CDO In Myogenesis Pathway antibodies  CDO In Myogenesis Pathway Diagram
 Cell Cycle Pathway antibodies  Cell Cycle Pathway Diagram
 Cell Cycle Pathway antibodies  Cell Cycle Pathway Diagram
 Cell Cycle Pathway antibodies  Cell Cycle Pathway Diagram
 Chronic Myeloid Leukemia Pathway antibodies  Chronic Myeloid Leukemia Pathway Diagram
 Chronic Myeloid Leukemia Pathway antibodies  Chronic Myeloid Leukemia Pathway Diagram
Diseases associated with ABL1 blocking peptideOrgans/Tissues associated with ABL1 blocking peptide
 Disease Name  Pubmed Publications
 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Antibodies  >395 publications with ABL1 and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
 Precursor Cell Lymphoblastic Leukemia-Lymphoma Antibodies  >164 publications with ABL1 and Precursor Cell Lymphoblastic Leukemia-Lymphoma
 Cell Transformation, Neoplastic Antibodies  >68 publications with ABL1 and Cell Transformation, Neoplastic
 Carcinogenesis Antibodies  >65 publications with ABL1 and Carcinogenesis
 Anemia Antibodies  >22 publications with ABL1 and Anemia
 Neoplasms, Experimental Antibodies  >17 publications with ABL1 and Neoplasms, Experimental
 Disease Models, Animal Antibodies  >15 publications with ABL1 and Disease Models, Animal
 Cardiovascular Diseases Antibodies  >13 publications with ABL1 and Cardiovascular Diseases
 Nervous System Diseases Antibodies  >9 publications with ABL1 and Nervous System Diseases
 Adenocarcinoma Antibodies  >8 publications with ABL1 and Adenocarcinoma
 Organ/Tissue Name  Pubmed Publications
 Blood Antibodies  >251 publications with ABL1 and Blood
 Bone Antibodies  >158 publications with ABL1 and Bone
 Bone Marrow Antibodies  >152 publications with ABL1 and Bone Marrow
 Spleen Antibodies  >15 publications with ABL1 and Spleen
 Prostate Antibodies  >12 publications with ABL1 and Prostate
 Lung Antibodies  >10 publications with ABL1 and Lung
 Heart Antibodies  >7 publications with ABL1 and Heart
 Lymph Antibodies  >7 publications with ABL1 and Lymph
 Lymph Node Antibodies  >7 publications with ABL1 and Lymph Node
 Liver Antibodies  >7 publications with ABL1 and Liver
Table BarTOPTable Bar
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions